|
1
|
Edelmann F, Knosalla C, Mörike K, Muth C,
Prien P and Störk S: Chronic heart failure. Dtsch Arztebl Int.
115:124–130. 2018.PubMed/NCBI
|
|
2
|
Füller M, von Bodman G, Kopf Dr, Brömsen
J, Sodian R and Block M: Chronic heart failure with reduced
ejection fraction: Standard treatment and new therapeutic options.
MMW Fortschr Med. 154:63–70. 2012.(In German).
|
|
3
|
Lena A, Coats AJS and Anker MS: Metabolic
disorders in heart failure and cancer. ESC Heart Fail. 5:1092–1098.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gyöngyösi M, Winkler J, Ramos I, Do QT,
Firat H, McDonald K, González A, Thum T, Díez J, Jaisser F, et al:
Myocardial fibrosis: Biomedical research from bench to bedside. Eur
J Heart Fail. 19:177–191. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Curtis LH, Whellan DJ, Hammill BG,
Hernandez AF, Anstrom KJ, Shea AM and Schulman KA: Incidence and
prevalence of heart failure in elderly persons, 1994–2003. Arch
Intern Med. 168:418–424. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hohendanner F, Messroghli D, Bode D,
Blaschke F, Parwani A, Boldt LH and Heinzel FR: Atrial remodelling
in heart failure: Recent developments and relevance for heart
failure with preserved ejection fraction. ESC Heart Fail.
5:211–221. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Richards AM: ST2 and prognosis in chronic
heart failure. J Am Coll Cardiol. 72:2321–2323. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu DY, Huang DJ, Yuan ZY, Zhao RP, Yan XW
and Wang MH; Chinese Investigators of SHIFT Study, : Efficacy and
safety analysis of ivabradine hydrochloride treatment of Chinese
patients with chronic heart failure: Subgroup analysis of Chinese
patients in the SHIFT study. Zhonghua Xin Xue Guan Bing Za Zhi.
45:190–197. 2017.(In Chinese). PubMed/NCBI
|
|
9
|
Ke Y, Xu D, Li M, Wu Z and Huang Y:
Effects of bisoprolol in combination with trimetazidine on the
treatment of heart failure and concomitant chronic obstructive
pulmonary disease. Pak J Med Sci. 32:1208–1212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fragasso G, Palloshi A, Puccetti P,
Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O and
Margonato A: A randomized clinical trial of trimetazidine, a
partial free fatty acid oxidation inhibitor, in patients with heart
failure. J Am Coll Cardiol. 48:992–998. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bernardi L, Spadacini G, Bellwon J, Hajric
R, Roskamm H and Frey AW: Effect of breathing rate on oxygen
saturation and exercise performance in chronic heart failure.
Lancet. 351:1308–1311. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suzuki T, Palus S and Springer J: Skeletal
muscle wasting in chronic heart failure. ESC Heart Fail.
5:1099–1107. 2018.PubMed/NCBI
|
|
14
|
Li CC, Chang SR and Shun SC: The self-care
coping process in patients with chronic heart failure: A
qualitative study. J Clin Nurs. 28:509–519. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
López B, Querejeta R, González A, Sánchez
E, Larman M and Díez J: Effects of loop diuretics on myocardial
fibrosis and collagen type I turnover in chronic heart failure. J
Am Coll Cardiol. 43:2028–2035. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang E-W, Jia X-S, Ruan C-W and Ge Z-R:
miR-487b mitigates chronic heart failure through inhibition of the
IL-33/ST2 signaling pathway. Oncotarget. 8:51688–51702.
2017.PubMed/NCBI
|
|
17
|
Boivin-Jahns V and Jahns R:
GPCR-autoantibodies in chronic heart failure. Front Biosci.
23:2065–2081. 2018. View
Article : Google Scholar
|
|
18
|
Brennan EJ: Chronic heart failure nursing:
Integrated multidisciplinary care. Br J Nurs. 27:681–688. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vergaro G and Iacoviello M: Is there a
‘renal paradox’ in chronic heart failure? Int J Cardiol.
267:139–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Canepa M, Ameri P, Lucci D, Nicolosi GL,
Marchioli R, Porcu M, Tognoni G, Franzosi MG, Latini R, Maseri A,
et al GISSI-HF Investigators, : Modes of death and prognostic
outliers in chronic heart failure. Am Heart J. 208:100–109. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Freitas P, Ferreira AM and Aguiar C:
Comparison of prognostic scores in chronic heart failure. JACC
Heart Fail. 6:887–888. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Simonavičius J, Knackstedt C and
Brunner-La Rocca HP: Loop diuretics in chronic heart failure: How
to manage congestion? Heart Fail Rev. 24:17–30. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wolfson AM, Fong M, Grazette L, Rahman JE
and Shavelle DM: Chronic heart failure management and remote
haemodynamic monitoring. Heart. 104:1910–1919. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fudim M, Ganesh A, Green C, Jones WS,
Blazing MA, DeVore AD, Felker GM, Kiefer TL, Kong DF, Boortz-Marx
RL, et al: Splanchnic nerve block for decompensated chronic heart
failure: splanchnic-HF. Eur Heart J. 39:4255–4256. 2018. View Article : Google Scholar : PubMed/NCBI
|
